Literature DB >> 24867235

Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation.

Sonja I Gringhuis1, Tanja M Kaptein1, Brigitte A Wevers1, Annelies W Mesman1, Teunis B H Geijtenbeek1.   

Abstract

Carbohydrate-specific signalling through DC-SIGN provides dendritic cells with plasticity to tailor immunity to the nature of invading microbes. Here we demonstrate that recognition of fucose-expressing extracellular pathogens like Schistosoma mansoni and Helicobacter pylori by DC-SIGN favors T helper cell type-2 (TH2) responses via activation of atypical NF-κB family member Bcl3. Crosstalk between TLR and DC-SIGN signalling results in TLR-induced MK2-mediated phosphorylation of LSP1, associated with DC-SIGN, upon fucose binding. Subsequently, IKKε and CYLD are recruited to phosphorylated LSP1. IKKε activation is pivotal for suppression of CYLD deubiquitinase activity and subsequent nuclear translocation of ubiquitinated Bcl3. Bcl3 activation represses TLR-induced proinflammatory cytokine expression, while enhancing interleukin-10 (IL-10) and TH2-attracting chemokine expression, shifting TH differentiation from TH1 to TH2 polarization. Thus, DC-SIGN directs adaptive TH2 immunity to fucose-expressing pathogens via an IKKε-CYLD-dependent signalling pathway leading to Bcl3 activation, which might be targeted in vaccination strategies or to prevent aberrant inflammation and allergy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867235     DOI: 10.1038/ncomms4898

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  50 in total

1.  Trichuris suis soluble products induce Rab7b expression and limit TLR4 responses in human dendritic cells.

Authors:  E J Klaver; T C T M van der Pouw Kraan; L C Laan; H Kringel; R D Cummings; G Bouma; G Kraal; I van Die
Journal:  Genes Immun       Date:  2015-05-21       Impact factor: 2.676

Review 2.  Dendritic Cells as an Alternate Approach for Treatment of Neurodegenerative Disorders.

Authors:  Veronika Brezovakova; Bernadeta Valachova; Jozef Hanes; Michal Novak; Santosh Jadhav
Journal:  Cell Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.046

Review 3.  C-type lectin receptors in the control of T helper cell differentiation.

Authors:  Teunis B H Geijtenbeek; Sonja I Gringhuis
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

Review 4.  Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding.

Authors:  Min Lu; Mary R Muers; Xin Lu
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-25       Impact factor: 94.444

Review 5.  Sentinels of the Type 2 Immune Response.

Authors:  Jakob von Moltke; Marion Pepper
Journal:  Trends Immunol       Date:  2017-11-06       Impact factor: 16.687

Review 6.  CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.

Authors:  Marie Lork; Kelly Verhelst; Rudi Beyaert
Journal:  Cell Death Differ       Date:  2017-03-31       Impact factor: 15.828

7.  DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance.

Authors:  Patricia Conde; Mercedes Rodriguez; William van der Touw; Ana Jimenez; Matthew Burns; Jennifer Miller; Manisha Brahmachary; Hui-ming Chen; Peter Boros; Francisco Rausell-Palamos; Tae Jin Yun; Paloma Riquelme; Alberto Rastrojo; Begoña Aguado; Joan Stein-Streilein; Masato Tanaka; Lan Zhou; Junfeng Zhang; Todd L Lowary; Florent Ginhoux; Chae Gyu Park; Cheolho Cheong; Joshua Brody; Shannon J Turley; Sergio A Lira; Vincenzo Bronte; Siamon Gordon; Peter S Heeger; Miriam Merad; James Hutchinson; Shu-Hsia Chen; Jordi Ochando
Journal:  Immunity       Date:  2015-06-09       Impact factor: 31.745

Review 8.  Innate immune receptors drive dengue virus immune activation and disease.

Authors:  Joris Sprokholt; Leanne C Helgers; Teunis Bh Geijtenbeek
Journal:  Future Virol       Date:  2017-11-17       Impact factor: 1.831

Review 9.  Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases.

Authors:  Mohammadmahdi Sabahi; Asef Joshaghanian; Mahsa Dolatshahi; Parnian Jabbari; Farzaneh Rahmani; Nima Rezaei
Journal:  J Mol Neurosci       Date:  2021-03-13       Impact factor: 3.444

10.  Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Authors:  Mohammad Murshid Alam; Cassie M Jarvis; Robert Hincapie; Craig S McKay; Jiri Schimer; Carlos A Sanhueza; Ke Xu; Roger C Diehl; M G Finn; Laura L Kiessling
Journal:  ACS Nano       Date:  2020-08-17       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.